- Fund Type: Open-End Fund
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: U.S.
Rydex Series - Biotechnology Fund
+ Add to WatchlistRYBOX:US
51.04 USD 0.30 0.59%As of 09:29:30 ET on 05/23/2013.
Snapshot for Rydex Series - Biotechnology Fund (RYBOX)
| Year To Date: | +29.90% | 3-Month: | +19.36% | 3-Year: | +31.46% | 52-Week Range: | 33.80 - 52.37 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +1.76% | 1-Year: | +44.07% | 5-Year: | +19.39% | Beta vs SPX: | 0.95 |
Fund Profile & Information for RYBOX
Rydex Series - Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests its assets in companies that are involved in the biotechnology industry, including companies involved in research and development, genetic or other biological engineering, and in the design, manufacture, or sale of related biotechnology products.
| Inception Date: | 09-01-2004 | Telephone: | 1-301-296-5100 |
|---|---|---|---|
| Managers: | MICHAEL P BYRUM / MIKE DELLAPA | ||
| Web Site: | www.guggenheiminvestments.com | ||
Fundamentals for RYBOX
| NAV | (on 2013-05-23) 51.04 |
|---|---|
| Assets (M) | (on 2013-05-23) 311.52 |
| Fund Leveraged | N |
| Minimum Investment | 2,500.00 |
| Minimum Subsequent Investment | 0.00 |
Dividends for RYBOX
| Dividend Type | Omitted |
|---|---|
| Dividend Frequency | Annual |
| Last Dividend Net | - |
| Dividend Yield (ttm) | - |
Fees & Expenses for RYBOX
| Front Load | 4.75 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 0.85 |
| Redemption Fee | 0.00 |
| 12b1 Fee | 0.25 |
| Expense Ratio | 1.61 |
Top Fund Holdings for RYBOX
Filing Date: 04/30/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Amgen Inc | 219,634 | 22,888,059 | 8.161% |
| Gilead Sciences Inc | 445,504 | 22,560,323 | 8.044% |
| Biogen Idec Inc | 89,233 | 19,535,781 | 6.966% |
| Celgene Corp | 147,257 | 17,386,634 | 6.199% |
| Regeneron Pharmaceuticals Inc | 58,419 | 12,568,264 | 4.481% |
| Vertex Pharmaceuticals Inc | 157,252 | 12,080,099 | 4.307% |
| Alexion Pharmaceuticals Inc | 112,574 | 11,032,252 | 3.934% |
| Life Technologies Corp | 126,620 | 9,330,628 | 3.327% |
| Illumina Inc | 118,646 | 7,675,210 | 2.737% |
| BioMarin Pharmaceutical Inc | 109,111 | 7,157,682 | 2.552% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page